CaviSense Inc., a Harvard/Tufts spin-out company, will make its first appearance at the Yankee Dental Congress, January 30 to February 1, at the Boston Convention & Exhibition Center. The company will be exhibiting at Booth #2132.
CaviSense has developed a patented, radiation-free technology designed to identify tooth-specific cariogenic activity through the detection of active enamel demineralization. During the meeting, clinicians will have the opportunity to observe brief, chairside demonstrations of the localized diagnostic sensor, which is intended to support identification of early demineralization that may not be apparent on radiographs or during visual examination.
“Radiographs remain essential, but when it comes to cariogenic activity they are not providing enough information. They show defects after they have already happened and are not completely safe” said Dr. Gili Naveh, company founder and the inventor of CaviSense. “Caries is a multifactorial pH disease, which requires pH related diagnostics, CaviSense helps clinicians see early demineralization that other techniques can’t, so they can intervene sooner, preserve healthy tooth structure and benefit their patients.”
The device is designed to integrate into hygiene and preventive care workflows and uses proprietary pH sensor technology to assess demineralization-prone environments on specific tooth surfaces.
“Caries management begins with early, targeted risk assessment,” said Brian Nový, DDS, Harvard lecturer, practicing dentist, and current President of the National CAMBRA (Caries Management by Risk Assessment) Coalition. “CaviSense is an effective and powerful tool that enables me to identify tooth surfaces susceptible to caries, which increases my chances of successfully managing and controlling the disease before the tooth cavitates, with technology I can place in the hands of parents and patients alike.”
“CaviSense enables me to identify cavity risk before there’s visible damage,” says Adam Silevitch, DMD, a pediatric dentist. “By measuring early acid activity, I can focus on prevention; implementing proactive, minimally invasive treatment strategies tailored to each child’s needs and often avoiding the need for traditional restorative procedures.”
“Early detection is the foundation of modern caries management,” said Dr. Naveh. “By identifying high-risk sites before cavitation occurs, clinicians can shift from restorative treatment to true disease prevention.”
Dental professionals attending the Yankee Dental Congress are invited to visit Booth #2132 to learn more about the technology, speak with clinical and product specialists, and review its potential role in preventive and risk-based caries management. Additional information is available at CaviSense.com, including details on in-office educational sessions in the New England region.
Figures and Images
CaviSense
